APOE ε4 Allele Dose and Time to Clinical Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Dementia: An ADNI Survival Analysis

Faizaan Fazal Khan, Goo-Rak Kwon · 2026

Read APOE ε4 Allele Dose and Time to Clinical Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Dementia: An ADNI Survival Analysis by Faizaan Fazal Khan, Goo-Rak Kwon (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13297606.txt.

Description

Faizaan Fazal Khan and Goo-Rak Kwon ask whether carrying more copies of a risk gene variant speeds the slide from mild memory trouble to Alzheimer's dementia, in a 2026 study. The variant, APOE ε4, is often treated as a simple yes-or-no factor. Records from a large imaging initiative covered 1,115 people with mild impairment, grouped by whether they held zero, one, or two copies.

Just over a third worsened to dementia during follow-up. Typical time without worsening fell sharply with each added copy. It ran from over eighteen years with no copy to under three and a half years with two copies. The no-copy figure rests on late follow-up, though. Each copy raised the hazard even after brain size and test scores were counted. Larger memory-centre volume, by contrast, protected.

Catalog record

CREATORFaizaan Fazal Khan, Goo-Rak Kwon
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13297606

Browse the full library · About the Tower of Babel